John F. Crary - Concepedia

Author

John F. Crary

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Ann C McKee, Charles L. White, Crary, John, Crary, John F., Crary, John Fonda, De Sanctis, Claudia, Edward Lee, Etty Cortes, J. Crary, J. F. Crary

302

Publications

11.8K

Citations

H-Index

135

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Allen Institute for Brain Science Boston University Columbia University Irving Medical Center The University of Texas Southwestern Medical Center

About

John F. Crary is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	42	5.4K
2	Engineering	3	3	249
3	Natural Sciences	3	3	626
4	Health Sciences	2	2	191
5	Public Health	1	1	20

John F. Crary

107

Publications

Citations

H-Index

Page 1

	Year	Citations
Primary age-related tauopathy (PART): a common pathology associated with human aging John F. Crary, John Q. Trojanowski, Julie A. Schneider, Acta Neuropathologica Alzheimer's DiseaseAgingPrimary Age-related TauopathyLongevityDementia	2014	1.5K
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A Anna‐Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, Nature	2022	471
Protein kinase Mζ is necessary and sufficient for LTP maintenance Douglas S.F. Ling, Larry S. Benardo, Peter A. Serrano, Nature Neuroscience Signal TransductionSignaling PathwayCell RegulationNatural SciencesProtein Kinase Mζ	2002	423
Axonally Synthesized ATF4 Transmits a Neurodegenerative Signal across Brain Regions Jimena Baleriola, Chandler A. Walker, Ying Y. Jean, Cell Neurodegenerative DiseasesNeuroregenerationSynthesized Atf4NeurophysiologyNeuroscience	2014	342
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease Minghui Wang, Panos Roussos, Andrew McKenzie, Genome Medicine	2016	335
The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy Kevin F. Bieniek, Nigel J. Cairns, John F. Crary, Journal of Neuropathology & Experimental Neurology	2021	293
Beta-amyloid deposition in chronic traumatic encephalopathy Thor D. Stein, Philip H. Montenigro, Victor E. Alvarez, Acta Neuropathologica Beta-amyloid DepositionAlzheimer's DiseaseNeurochemical BiomarkersBrain InjuryNeuroscience	2015	282
Protein Kinase Mζ Synthesis from a Brain mRNA Encoding an Independent Protein Kinase Cζ Catalytic Domain A. Iván Hernández, Nancy Blace, John F. Crary, Journal of Biological Chemistry M ZetaPkc ZetaCellular PhysiologySignaling PathwayCell Regulation	2003	265
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya, Nature Medicine Corticobasal DegenerationMedicineParkinson DiseaseHypokinetic Movement DisorderNeurological Disorder	2021	228
Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau Ismael Santa‐María, Maria Eugenia Alaniz, Neil Renwick, Journal of Clinical Investigation Tau ToxicityNeurochemical BiomarkersEpigeneticsSocial SciencesTranscriptional Regulation	2015	204

Page 1